These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 24457046

  • 1. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
    Rao T, Ranger JJ, Smith HW, Lam SH, Chodosh L, Muller WJ.
    Breast Cancer Res; 2014 Jan 23; 16(1):R11. PubMed ID: 24457046
    [Abstract] [Full Text] [Related]

  • 2. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.
    Webster MA, Hutchinson JN, Rauh MJ, Muthuswamy SK, Anton M, Tortorice CG, Cardiff RD, Graham FL, Hassell JA, Muller WJ.
    Mol Cell Biol; 1998 Apr 23; 18(4):2344-59. PubMed ID: 9528804
    [Abstract] [Full Text] [Related]

  • 3. Transgenic Polyoma middle-T mice model premalignant mammary disease.
    Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, Cardiff RD, MacLeod CL.
    Cancer Res; 2001 Nov 15; 61(22):8298-305. PubMed ID: 11719463
    [Abstract] [Full Text] [Related]

  • 4. PyV-mT-induced parotid gland hyperplasia as detected by altered lectin reactivity is not modulated by inducible nitric oxide deficiency.
    Ellies LG.
    Arch Oral Biol; 2003 Jun 15; 48(6):415-22. PubMed ID: 12749913
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
    Lahlou H, Sanguin-Gendreau V, Frame MC, Muller WJ.
    Breast Cancer Res; 2012 Feb 28; 14(1):R36. PubMed ID: 22373082
    [Abstract] [Full Text] [Related]

  • 10. Dual recombinase action in the normal and neoplastic mammary gland epithelium.
    Rädler PD, Vistisen K, Triplett AA, Dennaoui R, Li Y, Shrestha H, Ferraiuolo RM, Thangasamy A, Saur D, Wagner KU.
    Sci Rep; 2021 Oct 21; 11(1):20775. PubMed ID: 34675248
    [Abstract] [Full Text] [Related]

  • 11. The simultaneous induction of tumorigenesis and Cre-loxP recombination in mice.
    Sakahara M, Ohkawara H, Nakao K, Yokozaki H, Aiba A.
    Kobe J Med Sci; 2009 Mar 31; 54(6):E279-89. PubMed ID: 19628969
    [Abstract] [Full Text] [Related]

  • 12. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J.
    J Clin Invest; 2008 Jan 31; 118(1):64-78. PubMed ID: 18079969
    [Abstract] [Full Text] [Related]

  • 13. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology.
    Gunther EJ, Belka GK, Wertheim GB, Wang J, Hartman JL, Boxer RB, Chodosh LA.
    FASEB J; 2002 Mar 31; 16(3):283-92. PubMed ID: 11874978
    [Abstract] [Full Text] [Related]

  • 14. Generalized tetracycline induced Cre recombinase expression through the ROSA26 locus of recombinant mice.
    Bäckman CM, Zhang Y, Malik N, Shan L, Hoffer BJ, Westphal H, Tomac AC.
    J Neurosci Methods; 2009 Jan 15; 176(1):16-23. PubMed ID: 18801387
    [Abstract] [Full Text] [Related]

  • 15. Generation of H11-albumin-rtTA Transgenic Mice: A Tool for Inducible Gene Expression in the Liver.
    Li YS, Meng RR, Chen X, Shang CL, Li HB, Zhang TJ, Long HY, Li HQ, Wang YJ, Wang FC.
    G3 (Bethesda); 2019 Feb 07; 9(2):591-599. PubMed ID: 30591434
    [Abstract] [Full Text] [Related]

  • 16. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
    Yamazaki M, Akahane T, Buck T, Yoshiji H, Gomez DE, Schoeffner DJ, Okajima E, Harris SR, Bunce OR, Thorgeirsson SS, Thorgeirsson UP.
    Carcinogenesis; 2004 Sep 07; 25(9):1735-46. PubMed ID: 15166086
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.